A startup biotechnology platform company currently focused on precision oncology. EMPIRI is revolutionizing the way we treat cancer by providing empirical, personalized drug response data before treatments are selected for each patient by oncologists. We are building LDTs for specific cancer indications and a first-in-class automated cancer diagnostic instrument to scale our assays. We are also a 10x Genomic Certified Service Provider for single-cell analysis for clinical and preclinical studies.
| Website | https://www.empiricancer.com/ |
| Employees | 11 (3 on RocketReach) |
| Founded | 2018 |
| Address | 7505 Fannin Street Suite 200, Houston, Texas 77030, US |
| Industry | Biotechnology Research |
| Keywords | Drug Response Prediction, Precision Oncology, Therapeutic Target Identification, Personalized Cancer Therapy, Personalized Medicine, Patient Data Analytics, Tumor Profiling, Innovative Cancer Treatments, Cancer Treatment, Cancer Drug Development, Cancer Diagnostics, Drug Discovery, Cancer Care, Biotechnology Platform, Genomic Analysis, Molecular Diagnostics, Oncology Research, Clinical Trial Data, Cancer Biomarkers |
| Competitors | Roche, Thermo Fisher Scientific, Natera, Guardant Health, Foundation Medicine, Caris Life Sciences, NeoGenomics Laboratories, Invitae, Fulgent Genetics, Oncocyte Corporation +37 more (view full list) |
Looking for a particular Empiricancer employee's phone or email?
Empiricancer Questions
Dave Gallup is the Co-founder and Chief Executive Officer of Empiricancer.
3 people are employed at Empiricancer.
Empiricancer is based in Houston, Texas.
Top Empiricancer Employees
-
22
-
Viridiana Leyva-Aranda
CientÃfico at Empiricancer
Houston, TX, US -
Tade Son
Operations Manager at Empiricancer
Houston, TX, US2
